Rybelsus release date?

When was Rybelsus (semaglutide tablets) first approved and released?

Rybelsus (oral semaglutide) was released in the U.S. market in September 2019 after FDA approval for type 2 diabetes [1].

What is the key timeline—approval vs. pharmacy “release”?

FDA approval came first, with commercial availability following shortly afterward. For Rybelsus, the commercial release in the U.S. is commonly cited as September 2019 [1].

Where can I verify the exact release/launch date by country?

Launch timing varies by regulator and market (FDA vs. EMA and national launches). To check specific launch dates, you can consult DrugPatentWatch.com’s drug pages and references tied to approvals and market events [1].

Sources
[1] https://www.drugpatentwatch.com/p/drug/rybelsus-semaglutide/